-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PEvKsjmZqelwxTXfwCJ5jIbRp+fuiHVJpdDSW2an4/yzeLWqMJgp0G/Ca5vRfC3x NAOtGQKbieIJ6VFkL/0zmg== 0001158833-07-000038.txt : 20071220 0001158833-07-000038.hdr.sgml : 20071220 20071220104434 ACCESSION NUMBER: 0001158833-07-000038 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20071220 DATE AS OF CHANGE: 20071220 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIFE SCIENCES RESEARCH INC CENTRAL INDEX KEY: 0001158833 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 522340150 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-62457 FILM NUMBER: 071318083 BUSINESS ADDRESS: STREET 1: P. O. BOX 2360 STREET 2: METTLERS ROAD CITY: EAST MILLSTONE STATE: NJ ZIP: 08875 BUSINESS PHONE: 732-649-9961 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CASS BRIAN CENTRAL INDEX KEY: 0001165255 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: C/O HUNTINGDON LIFE SCIENCES LTD STREET 2: WOOLLEY ROAD, CITY: ALCONBURY STATE: A1 ZIP: 00000 BUSINESS PHONE: 44 1480 892 000 MAIL ADDRESS: STREET 1: C/O HUNTINGDON LIFE SCIENCES LTD STREET 2: WOOLLEY RD CITY: ALCONBURY HUNTINGDON STATE: X0 ZIP: PE28 4HS SC 13D/A 1 sched13da2.txt CASS FORM 13D A2 SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 2)(1) Life Sciences Research, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Voting Common Stock, $.01 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 5321691090 - -------------------------------------------------------------------------------- (CUSIP Number) Brian Cass c/o Life Sciences Research, Inc. Woolley Road Alconbury, Huntingdon Cambridgeshire PE28 4HS United Kingdom +44 (0) 1480 892 000 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 18, 2007 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [_]. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. (Continued on following pages) (Page 1 of Pages) - ---------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (SC13D-07/99) CUSIP No.5321691090 13D Page___ of __ Pages ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Brian Cass ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [x] ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* Not Applicable ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION United Kingdom ________________________________________________________________________________ 7 SOLE VOTING POWER 711,393 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 0 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 711,393 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 0 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 711,393 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* Not applicable [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.5% ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* IN ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No.5321691090 13D Page___ of __ Pages ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Brian Cass Private Pension Plan ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [x] ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* Not Applicable ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION United Kingdom ________________________________________________________________________________ 7 SOLE VOTING POWER 0 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 0 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 0 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 0 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 48,243 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* Not applicable [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) Less than 1%. ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* EP ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 13D Page of Pages ________________________________________________________________________________ Item 1. Security and Issuer. Class of Securities: Voting Common Stock, $.01 par value per share (the "Common Stock") Issuer: Life Sciences Research, Inc. (the "Issuer"), P.O. Box 2360, Mettlers Road, East Millstone, NJ 08875 ________________________________________________________________________________ Item 2. Identity and Background. (a) Name: Brian Cass (b) Business Address: Brian Cass c/o Life Sciences Research, Inc. Woolley Road Alconbury, Huntingdon Cambridgeshire PE28 4HS United Kingdom (c) Principal Occupation or Employment: President of the Issuer. (d) Criminal Convictions: None. (e) Civil Adjudication of Violation of Securities Laws: None. (f) Citizenship: United Kingdom citizen. ________________________________________________________________________________ Item 3. Source and Amount of Funds or Other Consideration. Not applicable ________________________________________________________________________________ Item 4. Purpose of Transaction. (a)-(j) This filing is made to report the transfer by Mr. Cass into his personal pension plan on December 18, 2007 of 16,750 shares of Common Stock. ________________________________________________________________________________ Item 5. Interest in Securities of the Issuer. (a) Beneficial Ownership by the Reporting Person: Number of Shares ---------------- Aggregate number of shares: 711,393 Percentage: 5.5%(based on 12,623,348 outstanding shares of common stock as of 10/29/07 as reported in the Issuer's Form 10-Q for the Quarter ended September 30, 2007 plus 255,500 shares subject to presently exercisable options held by Mr.Cass being deemed outstanding) (b) Sole Voting Power: 711,393 Shared Voting Power: 0 Sole Dispositive Power: 711,393 Shares Dispositive Power: 0 (c) Mr. Cass transferred 16,750 shares of Common Stock into his personal pension plan. (d) Not applicable. (e) Not applicable. ________________________________________________________________________________ Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. Not applicable. ________________________________________________________________________________ Item 7. Material to be Filed as Exhibits. None. ________________________________________________________________________________ SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. December 20, 2007 ---------------------------------------- (Date) /s/ Brian Cass ---------------------------------------- (Signature) Brian Cass ---------------------------------------- (Name/Title) Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). EDGARLink 7.0 (8/00) Ver. 3.1 -----END PRIVACY-ENHANCED MESSAGE-----